CC
ZYME icon

Corton Capital’s Zymeworks ZYME Stock Holding History

Corton Capital’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-59,355
Closed -$537K – 516
2023
Q1 		$537K Buy
+59,355
New +$518K 0.37% 53

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Corton Capital's ZYME Position: Q2 2023 in Review

Corton Capital sold out of Zymeworks (ZYME) in Q2 2023, closing a stake of 59,355 shares — an estimated $537K sold.

Corton Capital first reported a position in ZYME in Q1 2023 and held it in 1 quarter. The position peaked at $537K in Q1 2023. 137 funds tracked by Wall St. Rank hold ZYME as of Q2 2023.

  • Corton Capital reported no remaining Zymeworks position as of Q2 2023 after selling out during the quarter.
  • Corton Capital sold 59,355 Zymeworks shares in Q2 2023, an estimated $537K.
  • Corton Capital first reported a position in Zymeworks in Q1 2023 and held it in 1 quarter.
  • Corton Capital's Zymeworks position peaked at $537K in Q1 2023.
  • 137 funds tracked by Wall St. Rank held Zymeworks as of Q2 2023.

Based on Corton Capital's 13F filing for Q2 2023, filed 14 Aug 2023.